Your shopping cart is currently empty

S16–1029 is a selective, orally active butyrylcholinesterase (BChE) inhibitor with IC50 values of 11.35 nM for eqBChE and 48.1 nM for hBChE. It can cross the blood-brain barrier (BBB) and reach the central nervous system (CNS), making it suitable for Alzheimer's disease (AD) research [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | S16–1029 is a selective, orally active butyrylcholinesterase (BChE) inhibitor with IC50 values of 11.35 nM for eqBChE and 48.1 nM for hBChE. It can cross the blood-brain barrier (BBB) and reach the central nervous system (CNS), making it suitable for Alzheimer's disease (AD) research [1]. |
| Targets&IC50 | eqBCHE:11.35 nM, BCHE (human):48.1 nM |
| Molecular Weight | 447.49 |
| Formula | C23H25N7O3 |
| Cas No. | 2653349-51-8 |
| Smiles | C(C(NC1=CC=C(CCN2CCOCC2)C=C1)=O)N3C(=NC=4C3=CC=CC4)C=5C(N)=NON5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.